COA
TEVA icon

Charter Oak Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Charter Oak Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-430,300
Closed -$9.48M – 18
2024
Q4 		$9.48M Buy
+430,300
New +$7.83M 5.43% 9

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Ion Asset Management
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Menora Mivtachim Holdings
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Lingotto Investment Management
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Phoenix Financial
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Rubric Capital Management (New York)
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Harel Insurance Investments & Financial Services
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Charter Oak Advisors's TEVA Position: Q1 2025 in Review

Charter Oak Advisors sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2025, closing a stake of 430,300 shares — an estimated $9.48M sold.

Charter Oak Advisors first reported a position in TEVA in Q4 2024 and held it in 1 quarter. The position peaked at $9.48M in Q4 2024. 563 funds tracked by Wall St. Rank hold TEVA as of Q1 2025.

  • Charter Oak Advisors reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2025 after selling out during the quarter.
  • Charter Oak Advisors sold 430,300 Teva Pharmaceutical Industries Limited shares in Q1 2025, an estimated $9.48M.
  • Charter Oak Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q4 2024 and held it in 1 quarter.
  • Charter Oak Advisors's Teva Pharmaceutical Industries Limited position peaked at $9.48M in Q4 2024.
  • 563 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2025.

Based on Charter Oak Advisors's 13F filing for Q1 2025, filed 13 May 2025.